TCM
ALXO icon

Tang Capital Management’s ALX Oncology ALXO Stock Holding History

Tang Capital Management’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,158,265
Closed -$1.31M – 196
2025
Q2 		$1.31M Hold
3,158,265
– – 0.07% 141
2025
Q1 		$1.97M Sell
3,158,265
-138,618
-4% -$166K 0.11% 121
2024
Q4 		$5.51M Sell
3,296,883
-907,852
-22% -$1.4M 0.36% 66
2024
Q3 		$7.65M Buy
+4,204,735
New +$15.6M 0.55% 54

Other funds holding ALXO

VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Tang Capital Management's ALXO Position: Q3 2025 in Review

Tang Capital Management sold out of ALX Oncology (ALXO) in Q3 2025, closing a stake of 3,158,265 shares — an estimated $1.31M sold.

Tang Capital Management first reported a position in ALXO in Q3 2024 and held it in 4 quarters. The position peaked at $7.65M in Q3 2024. 61 funds tracked by Wall St. Rank hold ALXO as of Q3 2025.

  • Tang Capital Management reported no remaining ALX Oncology position as of Q3 2025 after selling out during the quarter.
  • Tang Capital Management sold 3,158,265 ALX Oncology shares in Q3 2025, an estimated $1.31M.
  • Tang Capital Management first reported a position in ALX Oncology in Q3 2024 and held it in 4 quarters.
  • Tang Capital Management's ALX Oncology position peaked at $7.65M in Q3 2024.
  • 61 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2025.

Based on Tang Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.